Degarelix
Degarelix for Prostate Cancer Treatment
A leading therapy for effective advanced prostate cancer management.
Degarelix for Hormone Therapy
Targeting hormone-driven cancers with proven high efficacy.
Degarelix's Therapeutic Benefits
Effective in reducing testosterone levels and managing symptoms.
Advancing Cancer Care with Degarelix
Partner with us to improve outcomes for prostate cancer patients.
FMoc-D-4-Aph(tBu-Cbm)-OH
FMoc-D-4-Aph(tBu-Cbm)-OH is a specialized amino acid derivative used in peptide synthesis and pharmaceutical development. This compound features an Fmoc (fluorenylmethoxycarbonyl) protective group on the amino terminus of D-4-phenylalanine (D-4-Aph), a chiral aromatic amino acid. The side chain of the phenylalanine residue is protected by a tert-butyl (tBu) carbobenzyloxy (Cbm) group, which combines steric protection with a high level of stability.
The incorporation of both the tBu and Cbm protecting groups makes this compound ideal for synthesizing peptides that require controlled reactivity and selective protection during the synthesis process. D-4-Aph is particularly useful for introducing specific structural features into peptides, providing additional stability and resistance to enzymatic degradation, making it valuable for the development of therapeutic peptides.
CAS No: 1433975-21-3
>>Download COA
Application:
- Peptide Synthesis: Serves as a building block for synthesizing peptides with D-amino acids, contributing to stability and resistance to proteolytic degradation.
- Pharmaceutical Development: Utilized in the design of peptides with enhanced pharmacokinetic properties and bioactivity.
- Drug Discovery: Supports the development of novel peptide-based drugs with specific biological targets and functions.
- Biochemical Research: A key tool for exploring peptide stability, structure, and enzymatic resistance in drug design and protein engineering.
Packing: Customized

Need more information/samples?